Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AL Amyloidosis, Waldenstrom Macroglobulinemia

Morie Gertz

MD MACP

🏢Mayo Clinic🌐USA

Professor

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Morie Gertz at Mayo Clinic has been the leading authority on AL amyloidosis (light chain amyloidosis) — a plasma cell disorder where misfolded immunoglobulin light chains deposit in organs causing progressive organ dysfunction. His work defining diagnostic criteria, prognostic scoring (Mayo staging), and treatment approaches for AL amyloidosis (including daratumumab combinations) has been foundational for this rare but serious disease related to myeloma.

Share:

🧪Research Fields 研究领域

AL amyloidosis treatment
light chain amyloidosis daratumumab
Waldenstrom macroglobulinemia ibrutinib
MYD88 Waldenstrom
systemic amyloidosis organ involvement

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Morie Gertz 的研究动态

Follow Morie Gertz's research updates

留下邮箱,当我们发布与 Morie Gertz(Mayo Clinic)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment